Company is expanding clinical trials of its psilocybin-based medicine. The post Compass Pathways Losses Tick Up on Increased R&D appeared first on...
Clairvoyant Therapeutics, a clinical stage biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is...
The article PharmaTher Enters into Agreement to Commercialize Ketamine for Rett Syndrome was originally published on Microdose. “We are pleased to have...
Silo Wellness Inc. (CSE: SILO | OTCQB: SILFF | FSE: 3K7A), Oregon’s only publicly traded psychedelics company, announces that the Jackson County Planning...
Despite a challenging economy, psychedelics companies have accelerated development. The post Recession Predictions Not Slowing Psychedelics Industry appeared...
The article Decoding the Difference Between 5-MeO-DMT and N, N-DMT was originally published on Microdose. Some of the more perplexing and intriguing psychedelics...
Novel treatments are required. That’s where psychedelics come in. The post Psychedelic Treatment for Suicide Could be in Sight appeared first on Green...
HAVN Life Sciences Inc. (CSE: HAVN | OTC: HAVLF | FSE: 5NP), a biotechnology company pursuing standardized extraction of psychoactive compounds and the...
Risk is part of investing. Even the most mature, well-established firms and stocks run the risk of declining to zero. However, that risk is even higher...
The article Numinus Launches Ketamine Program for Chronic and Serious Illness was originally published on Microdose. Numinus Launches Psychedelic-Assisted...